Boston Scientific (NYSE:BSX) shares have seen a significant bump today after the company released preliminary fourth quarter and fiscal year 2017 earnings that topped The Street and showed growth of approximately 9.9% and 7.9%, respectively.
For the fourth quarter, the Marlborough, Mass.-based company said it expects to report sales of $2.4 billion, just in line with the approximate $2.4 billion consensus on Wall Street.
The quarterly results represent 9.9% growth on a reported basis, 8.1% on an operational basis and approximately 6.8% on an organic basis, the company said in a press release.
For the full year, Boston Scientific said it expects to report sales of $9.1 billion, which is just ahead of the $9 billion consensus on The Street and representing growth of 7.9% on a reported basis. 7.8% on an operational basis and 6.6% on an organic basis.
Shares in Boston Scientific have risen 8.2% so far today, at $27.92 as of 3:16 p.m. EST.
Last month, Boston Scientific said it won FDA approval for its Vercise deep brain stimulation system designed to treat symptoms of Parkinson’s disease.
The post Boston Scientific shares jump on prelim Q4, FY2017 earnings appeared first on MassDevice.
from MassDevice http://ift.tt/2CVsPdf
Cap comentari:
Publica un comentari a l'entrada